Stimulant Drinks Linked To Heart Issues In Young Adults

High Caffeine Intake And Heart Risks

New preliminary research presented at the American Heart Association’s Scientific Sessions 2026 highlights a concerning link between caffeinated energy drinks, stimulant supplements, and serious cardiovascular events. An analysis of over 28,000 adverse-event reports submitted to the FDA between 2017 and 2025 indicates that products containing caffeine or other stimulants are associated with heart conditions far more frequently than other dietary products. This trend is particularly alarming given that sales of caffeinated energy drinks have more than doubled over the past decade, reaching a market value of over $20 billion in 2024.

The findings are particularly striking for adults between the ages of 18 and 34. This demographic is not typically viewed as being at high risk for cardiovascular events, yet approximately 45% of the reports linking stimulant products to heart issues involved this age group. The data showed similar patterns across both men and women, suggesting a broad risk within the young adult population. Healthcare professionals have already described specific cases of sudden cardiac death or irregular heart rhythms in people who consumed these products, many of whom had no known prior heart disease risks.

Statistical Findings From FDA Reports

The study compared 854 reports involving caffeine or stimulant-containing products against 27,491 reports regarding products without these ingredients, such as vitamins, protein bars, meal replacement shakes, and smoothies. The results revealed that cardiac arrest was reported roughly 11 times more often in connection with stimulant-containing products. Additionally, reports involving these drinks and supplements were 4.5 times more likely to include heart attacks and four times more likely to involve heart palpitations or ventricular arrhythmias, which are abnormal rhythms in the heart’s lower pumping chambers.

Other cardiovascular symptoms also appeared more frequently. Elevated heart rates were reported nearly three times more often, chest pain was reported 2.71 times more often, and fainting episodes were reported about twice as often compared to non-stimulant products. The researchers grouped these products by ingredients—including caffeine, methylxanthines like theobromine, guarana, yerba mate, and green tea or coffee extracts, as well as sympathomimetics such as synephrine, yohimbine, ephedra, DMAA, and higenamine—rather than by brand to identify general product trends.

The Gap In Safety Regulation

A significant point of concern is the regulatory status of these products. Because the FDA regulates energy drinks and stimulant supplements as foods or dietary supplements rather than medications, they do not undergo the same rigorous premarket safety testing required for pharmaceutical drugs. This allows products to enter the market with caffeine concentrations far exceeding those found in traditional beverages. Many consumers assume these products carry no real risk because they are marketed as everyday pick-me-ups and sold alongside soda and bottled water.

While consuming up to 400 mg of caffeine per day—roughly five 8-ounce cups of black coffee—is generally considered safe for most adults, many energy drinks contain up to three times more caffeine per fluid ounce than brewed coffee. Some pre-workout supplements contain more than 12 times the amount of caffeine per fluid ounce. For regular users, it is very easy to exceed the recommended daily limit, potentially leading to cardiovascular harm.

Understanding The Risk Factors

Researchers noted that while occasional consumption may pose a small risk for healthy individuals, regular use increases the likelihood of adverse events. However, the study does not prove a direct causal link, as other factors may influence the results. Potential variables include the timing of consumption, such as using stimulants before intense physical exercise, or mixing these products with alcohol or other drugs. There is also the possibility that some affected individuals had undiagnosed underlying heart conditions.

Medical professionals are encouraged to inquire about the use of these products when treating younger patients who experience fainting, chest pain, or palpitations. Experts emphasize that more systematic safety monitoring and further research are necessary to determine if these stimulant products are truly responsible for the reported heart events. Until full manuscripts are published in peer-reviewed journals, these findings remain preliminary, serving as a warning about the potential dangers of high-dose caffeine consumption in young, otherwise healthy adults.